hemostasis product catalogue
58Pages

{{requestButtons}}

Catalog excerpts

hemostasis product catalogue - 3

hemostasis product catalogue Hemostasis Product Catalogue Screening / Stats Thrombophilia Hemophilia Instrumentation Software Diagnostic Grifols, S.A. Passeig Fluvial, 24 08150 Parets del Vallès Barcelona - SPAIN Tel. [34] 935 710 400 Fax [34] 935 731 373 www.grifols.com

Open the catalog to page 3
hemostasis product catalogue - 4

Screening / Stats DG-DDimer Control DG-Fibrinlis DG-TT Thrombophilia DG-APC DG-DRVVT Confirm DG-EIA Control

Open the catalog to page 4
hemostasis product catalogue - 5

Hemophilia DG-Chrom FVIII DG-Latex vWF: Ag DG-EIA vWF Activity DG-EIA vWF DG-CBA Hemostasis Analyzer Sample Holder Sample Holder Red Stirrers Waste Tray Vials

Open the catalog to page 5
hemostasis product catalogue - 6

Screening / Stats

Open the catalog to page 6
hemostasis product catalogue - 7

DG-PT DG-APTT DG-CaCI2 0,025M DG-Ref DG-C1 DG-C2 DG-FIB DG-FIB L Human DG-Owren DG-DDimer kit DG-DDimer Control DG-Fibrinlis DG-TT DG-Fibroclotin

Open the catalog to page 7
hemostasis product catalogue - 8

Screening / Stats DG-PT DG-PT is intended for use in the determination of the Prothrombin Time (PT, Quick) and for measuring Derived Fibrinogen in optical systems. DG-PT is a thromboplastin extracted from rabbit brain dehydrated with acetone (40-50%), buffer, calcium ions and preservatives. The DG-PT Thromboplastin is a high sensitivity reagent with an ISI between 1.0 and 1.29, and is suitable for use in screening laboratories and Oral Anticoagulant Therapy. DG-PT is sensitive to factor deficiencies in the extrinsic pathway (deficiencies in factors II, V, VII and X). DG-PT is not sensitive...

Open the catalog to page 8
hemostasis product catalogue - 9

DG-CaCI 2 0,025M DG-CaCl2 0.025M is used as a source of calcium in the determination of the Activated Partial Thromboplastin Time (APTT), and in the determination of factors of the intrinsic pathway (VIII, IX, XI and XII). 213904 6 x 20 ml DG-CaCl2 0.025M, calcium chloride 0.025 M. 2400 in automatic micro systems (1200 in manual or macro systems). DG-Ref DG-Ref is intended for use as the calibration plasma for establishing calibration curves using the assigned value for each analyte. DG-Ref is prepared from a pool of normal human plasma, collected in sodium citrate, and is rapidly...

Open the catalog to page 9
hemostasis product catalogue - 10

Screening / Stats DG-C2 DG-C2 is intended for use as the assayed control plasma (Level 2) for quality control of the hemostasis parameters. DG-C2 is prepared from a pool of human plasma, collected in sodium citrate, freeze-dried and is further processed and adjusted to provide prolonged results in Coagulation Tests. Assayed ranges for: - Prothrombin Time (clotting) - Activated Partial Thromboplastin Time (clotting) - Fibrinogen (clotting) - Thrombin Time (clotting) - Reptilase Time (clotting) - Antithrombin (chromogenic) - Factors II, V, VII, VIII, IX, X, XI and XII (clotting) - Plasminogen...

Open the catalog to page 10
hemostasis product catalogue - 11

DG-DDimer kit The DG-DDimer kit is a latex test intended for use in the quantitative DG-DDimer Latex 4 x 2 ml. determination D-dimer assay in the Qs hemostasis analyzer. DG-DDimer Buffer 4 x 2 ml. DG-DDimer kit uses a specific anti D-dimer monoclonal antibody attached to DG-DDimer Dil 1 x 4 ml. the latex particles to determine active fibrinolysis in plasma. DG-DDimer Ref 1 x 1 ml. DG-DDimer Control 1 DG-DDimer Control 1 is intended for use as the assayed normal control plasmas for the 4 x 1 ml normal control quality control of DG-DDimer kit. DG-DDimer Control 2 DG-DDimer...

Open the catalog to page 11
hemostasis product catalogue - 12

Screening / Stats DG- Fibrinlis DG-Fibrinlis is a latex manual assay intended for use in the qualitative or semiquantitative determination of the D-dimer in plasma. Qualitative Method: To the test card: Add one drop DG-Fibrinlis Latex + 0.020 ml undiluted plasma Mix the card 3 minutes check for agglutination Semi-quantitative method: Prepare dilutions of the test plasmas with DG-Fibrinlis Buffer and run the test as described in the qualitative method for each dilution. Results interpretation: Qualitative method - Agglutination = Positive - No agglutination = Negative Semi-quantitative...

Open the catalog to page 12
hemostasis product catalogue - 15

DG-APC DG-DRVVT DG-DRVVT Confirm DG-DRVVT Control NEG DG-DRVVT Control POS DG-Chrom AT DG-Chrom AT L DG-Chrom PC DG-Chrom Hep DG-EIA PC DG-EIA PS DG-EIA PS Free DG-Chrom Plg DG-EIA Control DG-ADAMTS-13 Activity

Open the catalog to page 15
hemostasis product catalogue - 16

DG-APC Kit is a plasma based functional assay for the determination of resistance to activated protein C caused by the factor V Leiden mutation (FV: Q506). DG-APC kit is a clotting assay and differs from other functional APC resistance tests by acting specifically on the prothrombinase complex level. It is based on a FV-dependent prothrombin activator isolated from snake venom. Robustness and specificity of the assay is enhanced by elimination of possible disturbing influences by factors upstream the coagulation cascade and independency from calcium. Sample plasma is pre-diluted with DG-Dil...

Open the catalog to page 16
hemostasis product catalogue - 17

DG-DRVVT Confirm DG-DRVVT Confirm is a DRVV reagent rich in phospholipids in the purpose to confirm the presence of LAs in human plasmas that resulted positive after DG-DRVVT test. In a sample with LAs, the coagulation time with DG-DRVVT Confirm should be significantly lower than with DG-DRVVT because the extra phospholipid content of DG-DRVVT Confirm counteracts the LA antibodies. However, a normal sample will have the same coagulation time with both reagents. DG-DRVVT Control NEG DG-DRVVT Control NEG is intended for use as the assayed normal control for Lupus Anticoagulant (LA) testing....

Open the catalog to page 17
hemostasis product catalogue - 18

DG-Chrom AT L DG-Chrom AT L is a liquid chromogenic kit intended for use in the determination of the functional Antithrombin (AT) in human plasma. In the DG-Chrom AT L, the principle for determining AT is based on incubating the sample of diluted plasma with an excess of FXa and in the presence of heparin (heparin accelerates the reaction between AT and FXa). Residual FXa will attach to the chromogenic substrate, causing hydrolysis and later release of paranitroaniline (pNA). The amount of pNA is measured by absorbance at 405 nm and the result is inversely proportional to the level of AT...

Open the catalog to page 18
hemostasis product catalogue - 19

DG-Chrom Hep is a chromogenic kit used to determine quantitatively functional unfractioned (UFH) and low molecular weight (LMWH) Heparins in human plasma. The principle of heparin determination is based on the addition of Antithrombin to a sample containing heparin, followed by incubation in the presence of an excess of FXa (heparin accelerates the reaction between AT and FXa). Residual FXa will bind to the chromogenic substrate, causing its hydrolysis and later release of para-nitroaniline (pNA). The amount of pNA is monitored measuring the absorbance at 405 nm and the result is inversely...

Open the catalog to page 19

All Grifols catalogs and technical brochures

  1. BlisPack®

    8 Pages

  2. Wadiana®

    6 Pages

  3. PROMONITOR®

    2 Pages